Evidence map›Paper›PMID 38386489›Full record

ArticleMovement disorders clinical practice2024

Case-Fatality Rate in Parkinson's Disease: A Nationwide Registry Study.

Jussi O T Sipilä, Valtteri Kaasinen, Päivi Rautava, Ville Kytö

Abstract read
In one paragraph

Article in Movement disorders clinical practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Incidence, prevalence and mortality of Parkinson's disease in Greece.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  4. Article
  5. Article
  6. Update: Descriptive epidemiology of Parkinson disease.Parkinsonism & related disorders · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jussi O T SipiläDepartment of Neurology, Siun Sote North Karelia Central Hospital, Joensuu, Finland.ORCID 0000-0003-0183-9054
Valtteri KaasinenClinical Neurosciences, University of Turku, Turku, Finland.ORCID 0000-0002-3446-7093
Päivi RautavaDepartment of Public Health, University of Turku, Turku, Finland.
Ville KytöTurku Clinical Research Center, Turku University Hospital, Turku, Finland.

Funding

Finnish Governmental VTR-fundingPaavo Nurmen SäätiöSuomen KulttuurirahastoSydäntutkimussäätiö
6 · The paper itself

Abstract

backgroundPatients with Parkinson's disease (PD) may have an increased risk of mortality, but robust estimates are lacking.

objectiveTo compare mortality rates nationally between patients with PD and controls.

methodsThe case-fatality rates of Finnish PD patients diagnosed in 2004-2018 (n = 23,688; 57% male, mean age at diagnosis = 71 years) and randomly selected sex- and age-matched control subjects (n = 94,752) were compared using data from national registries. The median follow-up duration was 5.8 years (max 17 years).

resultsThe case-fatality rate in patients with PD was higher than that in matched controls (HR 2.29; 95% CI 2.24-2.33; P < 0.0001). Excess fatality among PD patients was already present at 1 year from diagnosis and then plateaued at 29% at 12 years after diagnosis. The long-term relative hazard of death in PD patients vs. matched controls did not differ based on sex. Patients with early-onset PD (age at diagnosis <50 years old) had the highest relative hazard of death (HR 3.36) compared to matched control subjects, and the relative hazard decreased with higher age at diagnosis. The seven-year excess risk of death decreased during the study period, especially in men. In patients with PD, male sex, increasing age, and increasing comorbidity burden were associated with an increased risk of death.

conclusionsAn increased risk of death among PD patients was evident from early on. The increase in risk was greatest among young-onset patients. The excess risk in early PD declined during the study period, particularly in men. The reasons for this are unknown.

Indexed as

Parkinson DiseaseAgedCase-Control StudiesComorbidityFemaleHumansMaleMiddle AgedRegistriesScandinavians and Nordic Peoplemortalityneurodegenerative diseasesneuroepidemiologyprognosissurvival

Identifiers

PMID38386489
PMCPMC10883402

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.